Share
Publications
-
14 June 2011 /Prices and reimbursement
Number of applications for individual reimbursement of medicines in 2010
In 2010, we reached decisions in a total of 144,324 individual reimbursement applications against 138,714 in 2009, corresponding to an increase of 4 %. The figure breaks down to approx. 96,000 applications for single reimbursement (about 3 % fewer than in 2009), approx. 34,000 applications for reimbursement for the chronically ill (about 30 % more than in 2009), approx. 12,000 applications for reimbursement for the terminally ill (about 7 % more than in 2009) and approx. 2,800 applications for increased reimbursement (about 14 % more than in 2009).
-
27 April 2011 /About us
-
05 November 2010 | Updated 30 March 2011 /About us
Performance contract 2010/2011
The Danish Medicines Agency and the Ministry of Interior and Health have signed a performance contract.
-
23 March 2011 /Prices and reimbursement
Annual report of the Reimbursement Committee 2010
In 2010, the Reimbursement Committee reviewed 20 applications for general reimbursement and 1719 applications for individual reimbursement.
-
03 March 2011 /Publications - miscellaneous
Perspectives and challenges of the Danish Medicines Agency
Over the past few years, we have developed a strategy to address the challenges of the Danish Medicines Agency and to prioritise accordingly. Our strategy has fostered a number of action plans, which describe the areas that we want to focus on in particular.
-
06 January 2011 /Prices and reimbursement
Elderly people’s consumption of medicinal products
Elderly people's consumption of medicinal products is increasing. Regarding all medicine consumers over the age of 64, the sale measured in DKK and defined daily doses has generally increased from 1999 to 2001.
-
01 November 2010 /Product areas
Annual report on human tissues and cells 2009
The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establishments and gynaecology clinics in Denmark in the period January to December 2009.
-
29 October 2010 /Side effects and trials
Assessment of safety of methylphenidate in ADHD treatment
The Danish Medicines Agency has reviewed the data on consumption and side effects of methylphenidate-containing medicine, which is authorised for the treatment of ADHD and narcolepsy.
-
17 August 2010 /Product areas
Report on the blood product area in 2009
In 2009, 358.000 blood collections were made in Denmark. This is approximately 4.000 collections more than the previous year. Moreover, approximately 332.000 units of red blood cells (erythrocytes) were used in connection with blood transfusions in 2009.
-
15 June 2010 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2009
In 2009, 186 reports of medicinal product defects were registered, which is slightly more than in 2008. Compared to 2008, the reporting sources and types of defects have shifted, and reports from the Danish Medicines Agency's own control system accounted for a larger share in 2009 compared to 2008.
-
14 June 2010 /Authorisation and supervision
-
20 May 2010 /Publications - miscellaneous
-
23 April 2010 /Prices and reimbursement
-
31 March 2010 /Prices and reimbursement
-
29 March 2010 /Side effects and trials
Danish Medicines Agency’s annual pharmacovigilance report 2009
The annual report offers an insight into the pharmacovigilance work performed by the Danish Medicines Agency in 2009.
-
05 March 2010 /Product areas
Annual report on human tissues and cells 2008
The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establisments and gynaecology clinics in Denmark in the period January to December 2008
-
15 December 2009 /Prices and reimbursement
Considerable increase in consumption of antidiabetic drugs from 1999 to 2008 in Denmark
The number of people in Denmark being diagnosed with diabetes has soared for the past many years, and the same can be said for the sums spent on treatment and medicines for antidiabetics.
-
01 December 2009 /Prices and reimbursement
Sale of dose dispensed medicine in the primary Danish health sector 2004-2008
Dose dispensing was launched in Denmark in 2002, and the use of dose dispensing has increased since then. Dose dispensing is used by all age groups, but the share of users increases with age, and women more frequently use dose dispensed medicine than men.
-
02 September 2009 /Product areas
Report on the blood product area in 2008
The blood product report is published every year based on figures from the Danish blood centres and the Blood-donors in Denmark.
-
13 July 2009 | Updated 27 August 2009 /Prices and reimbursement
Effective effort against the excessive use of benzodiazepines in Denmark
A long-term use of sleeping medicine and anti-anxiety drugs of the benzodiazepine type should be avoided, as it can lead to addiction, dizziness, memory impairment and concentration difficulties, as well as an increased risk of falling. Throough the years, many political health care initiatives have therefore been launched in order to reduce the consumption of these medicines.
